Publicacions en col·laboració amb investigadors/es de Erasmus University Medical Center (6)

2024

  1. Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 42, Núm. 12, pp. 1350-1356

2023

  1. Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial

    Annals of Oncology, Vol. 34, Núm. 5, pp. 468-476

2022

  1. A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry

    Journal of Thoracic Oncology, Vol. 17, Núm. 5, pp. 661-674

2020

  1. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

    The Lancet Oncology, Vol. 21, Núm. 7, pp. 914-922

2008

  1. Evaluation of functional single nucleotide polymorphisms of different genes coding for the immunoregulatory molecules in patients with monoclonal large granular lymphocyte lymphocytosis

    Human Immunology, Vol. 69, Núm. 2, pp. 101-107

  2. Expanded cells in monoclonal TCR-άΒ+/CD4+/NKa+/CD8-/+dim T-LGL lymphocytosis recognize hCMV antigens

    Blood, Vol. 112, Núm. 12, pp. 4609-4616